Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors

Qinqin Xu1, Xinyue Lan1,2, Huimin Lin1

  • 1Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China.

Insights

The tumor microenvironment (TME) drives drug resistance in cancer. Nanomedicines can remodel the TME to overcome this resistance and enhance antitumor efficacy.

Area of Science:

  • Oncology
  • Nanotechnology
  • Drug Discovery

Background:

  • The tumor microenvironment (TME) facilitates tumor cell survival and promotes drug resistance.
  • Understanding TME complexity is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To review the relationship between TME characteristics and tumor drug resistance.
  • To explore nanomedicine strategies for TME remodeling to combat drug resistance.

Main Methods:

  • Literature review focusing on TME factors (hypoxia, acidity, immunity, metabolism, microorganisms).
  • Analysis of nanomedicine approaches for TME modulation in cancer therapy.

Main Results:

  • Specific TME features significantly contribute to multidrug resistance in tumors.
  • TME remodeling strategies, particularly via nanomedicine, show promise in enhancing antitumor activity.

Conclusions:

  • Targeting the TME is a viable strategy to overcome cancer drug resistance.
  • Nanomedicine offers innovative solutions for TME-based cancer treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K